Tree Line Asia Master Fund sells 9.10 lakh shares of Claris Lifesciences: Report

08 Jan 2014 Evaluate

Tree Line Asia Master Fund (Singapore) PTE has reportedly sold 9.10 lakh shares of Claris Lifesciences through the open market route. The shares were sold on an average price of Rs 202.78 valuing the transaction to Rs 18.45 crore.

Claris is one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.

Peers
Company Name CMP
Redington 216.95
Adani Enterprises 3263.50
Amrapali Industries 15.35
Rashi Peripheral 341.75
Compuage Infocom 3.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.